Skip to content
Capital for Cures
  • Our Firm
    • Engage overview How we work with both sides of the table
    • For asset owners TTOs, biotechs, foundations, licensors
    • For capital partners Funds, family offices, institutions
  • Examples
  • Research
  • Periodic Table
  • Insights ↗
Submit an asset
Engage

Two sides of every origination.

Royalty origination is two-sided. Asset owners need a partner who can identify their position, reconstruct the terms, and benchmark it against four decades of comparable transactions. Capital partners need origination of opportunities in segments their own teams cannot systematically reach. We work with both. We do not act as principal, agent, or placement agent on either side; the transactions remain between the holders and the buyers.

Asset

For asset owners

University tech transfer offices · biotechs with partnered assets · research foundations · mid-cap licensors

Submit a royalty stream and receive a no-obligation indicative analysis. We benchmark the rate, model the cash flows against four decades of comparable transactions, and outline carve-out scenarios sized to the position. If the asset matches a capital partner's mandate, we make a warm introduction. The transaction itself remains between you and the buyer.

For asset owners →
Capital

For capital partners

Specialist royalty funds · family offices · institutional investors · sovereign and pension capital

Receive originated long-tail royalty opportunities that sit outside the practical reach of in-house BD teams. Thematically grouped, structurally analysed, and benchmarked against the corpus. The output is origination flow with research depth — opportunities for you to pursue, transact, and underwrite under your own diligence.

For capital partners →
Capital for Cures
Pharmaceutical royalty origination platform.
Schoffelgasse 3
8001 Zürich, Switzerland
sebastian@capitalforcures.com

The firm

  • Our Firm
  • Contact
  • Privacy and Cookies

Engage

  • For asset owners
  • For capital partners

Reference

  • Examples
  • Research
  • Periodic Table
  • Insights ↗

Important. Capital for Cures AG is a Zurich-based pharmaceutical royalty origination platform. It is not a regulated investment manager, broker-dealer, or placement agent, and does not manage, hold, solicit, or place third-party assets. Our role is to identify and originate royalty opportunities through research, structural analysis, and benchmarking, and to introduce parties; transactions are between the holders and the buyers. Nothing on this site constitutes investment advice, a recommendation, or an offer or solicitation to buy or sell any security or financial instrument. All asset-specific information shown on this site is illustrative; it is derived from publicly available sources and was correct, to the best of our knowledge, as of the date of publication and may have changed since. The worked examples on the Examples pages reference real public assets but do not represent transactions executed, advised on, or recommended by Capital for Cures. Capital for Cures AG accepts no liability for any loss arising from reliance on the information presented here.

© 2026 Capital for Cures AG · Zürich, Switzerland

Cookies and analytics on this site.

We use Google Analytics to understand how the site is used. No advertising, no third-party trackers beyond that. Accept to allow analytics, or reject to opt out. See our privacy and cookies notice for the full picture.